article Open AccessTop 1% cited
Guidelines of care for the management of atopic dermatitis
Journal of the American Academy of Dermatology · 2014 · Vol. 71(1) · pp. 116–132
Lawrence F. Eichenfield✉(University of California San Diego)Wynnis L. Tom(University of California San Diego)Timothy G. Berger(University of California, San Francisco)Alfons Krol(Oregon Health & Science University)Amy S. Paller(Northwestern University)Kathryn Schwarzenberger(University of Tennessee Health Science Center)James N. Bergman(University of British Columbia)Sarah L. Chamlin(Lurie Children's Hospital)David E. Cohen(New York University)Kevin D. Cooper(Western University of Health Sciences)Kelly M. Cordoro(University of California, San Francisco)Dawn Marie R. Davis(Mayo Clinic)Steven R. Feldman(Wake Forest University)Jon M. Hanifin(Oregon Health & Science University)David J. Margolis(University of Pennsylvania)Robert A. SilvermanEric L. Simpson(Oregon Health & Science University)Hywel C Williams(National Health Service)Craig A. Elmets(University of Alabama at Birmingham)Julie Block(National Eczema Association)Christopher G. Harrod(American Academy of Dermatology)Wendy Smith Begolka(American Academy of Dermatology)Robert Sidbury(Seattle Children's Hospital)
Dermatology and Skin DiseasesFood Allergy and Anaphylaxis ResearchAllergic Rhinitis and SensitizationMedicineAtopic dermatitisDermatologyMEDLINE
MeSH terms
Administration, TopicalAdrenal Cortex HormonesChronic DiseaseDermatitis, AtopicEmollientsHistamine AntagonistsHumansPractice Guidelines as TopicEvidence-Based MedicineCalcineurin Inhibitors
Citations
1,176
FWCI
73.69
field-weighted impact
References
140
Percentile
100%
vs. same field & year
Citations per year
Cited by
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
British Journal of Dermatology · 2017 · 469 citations
Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial
British Journal of Dermatology · 2016 · 410 citations
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
Journal of the American Academy of Dermatology · 2016 · 549 citations
References
Topical corticosteroid phobia in patients with atopic eczema
British Journal of Dermatology · 2000 · 584 citations
Adverse effects of topical glucocorticosteroids
Journal of the American Academy of Dermatology · 2005 · 1,102 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.